VolitionRx director Mickie Henshall to depart board; no disagreement cited

Filed May 15, 2026 · Period ending May 12, 2026 · ~1 min read

Key Changes

• low

  Director Mickie Henshall, who joined the board in August 2022, will not stand for re-election at the 2026 Annual Meeting. The filing explicitly states her departure involves no disagreement with company operations, policies, or practices.

  Item 5.02 verify on EDGAR →
• low

  Board size will shrink from eight to seven directors effective immediately before the 2026 Annual Meeting, a planned reduction tied to Henshall's departure rather than any governance restructuring.

  Item 5.02 verify on EDGAR →